Abstract
Fluoroquinolones (FQ) are an important family of synthetic antimicrobial agents being clinically used over the past thirty years. Currently some FQ are under investigation for the treatment of multidrug-resistant tuberculosis (MDRTB), defined as resistance to at least isoniazid and rifampicin, and are under investigation as first-line drugs. Their main biological target in Mycobacterium tuberculosis is the DNA gyrase, a topoisomerase II encoded by gyrA and gyrB that is essential to maintain the DNA supercoil. It has been demonstrated that mutations in short regions of DNA gyrase are associated with quinolone resistance or hypersusceptibility and take place in several MDR clinical isolates of M. tuberculosis. In this article we update§ our previous review (Carta et al. Anti-infective agents, 2008, 7, 134-147) about the anti mycobacterial properties, mode of action and structure activity relationship (SAR) studies of the known quinolone derivatives. Furthermore, we update the synthesis and activity of 3,9-disubstituted-6-oxo-6,9-dihydro-3H-[1,2,3]-triazolo[4,5-h,g]quinolonecarboxylic acids and their esters as a new class of potent and selective anti-mycobacterial agents, coupled with absence of cytotoxicity. Furthermore, particularly interesting is their activity against MDR M. tuberculosis.
Keywords: Anti-mycobacterial activity, DNA gyrase inhibitors, MDR-TB, quinolones, SAR analysis, triazoloquinolones antitubercular activity.
Anti-Infective Agents
Title:SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update
Volume: 11 Issue: 1
Author(s): Irene Briguglio, Sandra Piras, Paola Corona, Maria A. Pirisi, Daniela Jabes and Antonio Carta
Affiliation:
Keywords: Anti-mycobacterial activity, DNA gyrase inhibitors, MDR-TB, quinolones, SAR analysis, triazoloquinolones antitubercular activity.
Abstract: Fluoroquinolones (FQ) are an important family of synthetic antimicrobial agents being clinically used over the past thirty years. Currently some FQ are under investigation for the treatment of multidrug-resistant tuberculosis (MDRTB), defined as resistance to at least isoniazid and rifampicin, and are under investigation as first-line drugs. Their main biological target in Mycobacterium tuberculosis is the DNA gyrase, a topoisomerase II encoded by gyrA and gyrB that is essential to maintain the DNA supercoil. It has been demonstrated that mutations in short regions of DNA gyrase are associated with quinolone resistance or hypersusceptibility and take place in several MDR clinical isolates of M. tuberculosis. In this article we update§ our previous review (Carta et al. Anti-infective agents, 2008, 7, 134-147) about the anti mycobacterial properties, mode of action and structure activity relationship (SAR) studies of the known quinolone derivatives. Furthermore, we update the synthesis and activity of 3,9-disubstituted-6-oxo-6,9-dihydro-3H-[1,2,3]-triazolo[4,5-h,g]quinolonecarboxylic acids and their esters as a new class of potent and selective anti-mycobacterial agents, coupled with absence of cytotoxicity. Furthermore, particularly interesting is their activity against MDR M. tuberculosis.
Export Options
About this article
Cite this article as:
Briguglio Irene, Piras Sandra, Corona Paola, A. Pirisi Maria, Jabes Daniela and Carta Antonio, SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update, Anti-Infective Agents 2013; 11 (1) . https://dx.doi.org/10.2174/22113626130109
DOI https://dx.doi.org/10.2174/22113626130109 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Understanding the Structure, Activity and Inhibition of Chorismate Synthase from Mycobacterium tuberculosis
Current Medicinal Chemistry Preliminary X-Ray Crystallographic Studies Of The Mycobacterium Tuberculosis Hsp16.3 Molecular Chaperone
Protein & Peptide Letters Vitamin D and Tuberculosis
Current Respiratory Medicine Reviews Chaperone-like Activity of alpha-Crystallin and Other Small Heat Shock Proteins
Current Protein & Peptide Science Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence
Medicinal Chemistry Significance of P2X7 Receptor Variants to Human Health and Disease
Recent Patents on DNA & Gene Sequences Essential Oils with Microbicidal and Antibiofilm Activity
Current Pharmaceutical Biotechnology New Opportunities in the Structure-based Design of Anti-Protozoan Agents
Current Topics in Medicinal Chemistry Recent Developments in Antimalarial Drug Discovery
Anti-Infective Agents in Medicinal Chemistry Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets Synthesis, Anticlotting and Antiplatelet Effects of 1,2,3-Triazoles Derivatives
Medicinal Chemistry Flexible Bronchoscopy Biopsy Tools and Techniques to Optimize Diagnostic Yield: A Contemporary Review
Current Respiratory Medicine Reviews Preliminary Studies on Ligand-based Design and Evaluation of New Mycobacterial ATP Synthase Inhibitors
Current Drug Therapy Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response
Anti-Cancer Agents in Medicinal Chemistry Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research <i>In Silico</i> Assessment of the Acute Toxicity of Chemicals: Recent Advances and New Model for Multitasking Prediction of Toxic Effect
Mini-Reviews in Medicinal Chemistry QSAR Multi-Target in Drug Discovery: A Review
Current Computer-Aided Drug Design Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives
Current Pharmaceutical Design Bacterial Infection Probes and Imaging Strategies in Clinical Nuclear Medicine and Preclinical Molecular Imaging
Current Topics in Medicinal Chemistry